238 related articles for article (PubMed ID: 30125624)
1. Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione.
Das TK; Javadzadeh A; Dey A; Sabesan P; Théberge J; Radua J; Palaniyappan L
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():94-102. PubMed ID: 30125624
[TBL] [Abstract][Full Text] [Related]
2. The impact of alcohol and tobacco use on in vivo glutathione in youth with bipolar disorder: an exploratory study.
Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
J Psychiatr Res; 2014 Aug; 55():59-67. PubMed ID: 24755258
[TBL] [Abstract][Full Text] [Related]
3. Risky alcohol use in young persons with emerging bipolar disorder is associated with increased oxidative stress.
Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
J Affect Disord; 2013 Sep; 150(3):1238-41. PubMed ID: 23838389
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal proton magnetic resonance spectroscopy study investigating oxidative stress as a result of alcohol and tobacco use in youth with bipolar disorder.
Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
J Affect Disord; 2015 Apr; 175():481-7. PubMed ID: 25679204
[TBL] [Abstract][Full Text] [Related]
5. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.
Kubo H; Nakataki M; Sumitani S; Iga JI; Numata S; Kameoka N; Watanabe SY; Umehara H; Kinoshita M; Inoshita M; Tamaru M; Ohta M; Nakayama-Yamauchi C; Funakoshi Y; Harada M; Ohmori T
J Affect Disord; 2017 Jan; 208():139-144. PubMed ID: 27770643
[TBL] [Abstract][Full Text] [Related]
6. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
[TBL] [Abstract][Full Text] [Related]
7. Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS Study.
Soeiro-de-Souza MG; Pastorello BF; Leite Cda C; Henning A; Moreno RA; Garcia Otaduy MC
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207914
[TBL] [Abstract][Full Text] [Related]
8. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
Zavitsanou K; Katsifis A; Mattner F; Huang XF
Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
[TBL] [Abstract][Full Text] [Related]
9. Glutathione and glutamate in schizophrenia: a 7T MRS study.
Kumar J; Liddle EB; Fernandes CC; Palaniyappan L; Hall EL; Robson SE; Simmonite M; Fiesal J; Katshu MZ; Qureshi A; Skelton M; Christodoulou NG; Brookes MJ; Morris PG; Liddle PF
Mol Psychiatry; 2020 Apr; 25(4):873-882. PubMed ID: 29934548
[TBL] [Abstract][Full Text] [Related]
10. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS.
Shukla D; Mandal PK; Tripathi M; Vishwakarma G; Mishra R; Sandal K
Hum Brain Mapp; 2020 Jan; 41(1):194-217. PubMed ID: 31584232
[TBL] [Abstract][Full Text] [Related]
12. Functional dysconnectivity of anterior cingulate subregions in schizophrenia and psychotic and nonpsychotic bipolar disorder.
Liang S; Cao B; Deng W; Kong X; Zhao L; Jin Y; Ma X; Wang Y; Li X; Wang Q; Guo W; Du X; Sham PC; Greenshaw AJ; Li T
Schizophr Res; 2023 Apr; 254():155-162. PubMed ID: 36889182
[TBL] [Abstract][Full Text] [Related]
13. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression.
Koethe D; Llenos IC; Dulay JR; Hoyer C; Torrey EF; Leweke FM; Weis S
J Neural Transm (Vienna); 2007; 114(8):1055-63. PubMed ID: 17370106
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
15. Evidence of altered membrane phospholipid metabolism in the anterior cingulate cortex and striatum of patients with bipolar disorder I: A multi-voxel (1)H MRS study.
Cao B; Stanley JA; Selvaraj S; Mwangi B; Passos IC; Zunta-Soares GB; Soares JC
J Psychiatr Res; 2016 Oct; 81():48-55. PubMed ID: 27376506
[TBL] [Abstract][Full Text] [Related]
16. Relationship of executive functioning deficits to N-acetyl aspartate (NAA) and gamma-aminobutyric acid (GABA) in youth with bipolar disorder.
Huber RS; Kondo DG; Shi XF; Prescot AP; Clark E; Renshaw PF; Yurgelun-Todd DA
J Affect Disord; 2018 Jan; 225():71-78. PubMed ID: 28800423
[TBL] [Abstract][Full Text] [Related]
17. Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder.
Ehrlich A; Schubert F; Pehrs C; Gallinat J
Psychiatry Res; 2015 Aug; 233(2):73-80. PubMed ID: 26050195
[TBL] [Abstract][Full Text] [Related]
18. Anterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: a potential new tool for diagnosis.
Shi XF; Forrest LN; Kuykendall MD; Prescot AP; Sung YH; Huber RS; Hellem TL; Jeong EK; Renshaw PF; Kondo DG
J Affect Disord; 2014; 167():25-9. PubMed ID: 25082110
[TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.
Kuloglu M; Ustundag B; Atmaca M; Canatan H; Tezcan AE; Cinkilinc N
Cell Biochem Funct; 2002 Jun; 20(2):171-5. PubMed ID: 11979513
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
Matosin N; Fernandez-Enright F; Frank E; Deng C; Wong J; Huang XF; Newell KA
J Psychiatry Neurosci; 2014 Nov; 39(6):407-16. PubMed ID: 24949866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
